Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

d3 Medicine

d3 Medicine
2012 FOUNDED
M&A STATUS
11-20 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of oncology drug development and research. The company focuses on developing medicines for infectious diseases, oncology and inflammation. It offers development programs using contemporary data analysis methods to increase efficiency, improve decision making and create opportunities to accelerate patient access to medicines.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 4 Century Drive
  • Parsippany-Troy Hills, NJ 07054
  • United States

d3 Medicine Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore d3 Medicine‘s full profile, request access.

Request full access to PitchBook

d3 Medicine Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Graybug Vision Venture Capital-Backed Redwood City, CA 00000 00000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 000.00 000000000 000.00
00000000 Formerly VC-backed Malvern, PA 00 00000 00000000 00000
000000 Formerly VC-backed Redwood City, CA 00 00000 00000000 00000
00000000 000000000 Pending Transaction (M&A) New York, NY 000000&0
To view this company’s complete list of competitors, request access »